| Hans-Günter Meyer-Thompson | Naltrexon
Improving naltrexone compliance and outcomes with putative pro-dopamine regulator KB220, compared to treatment as usual.
Improving naltrexone compliance and outcomes with putative pro-dopamine regulator KB220, compared to treatment as usual.
Blum K, Lott L, Baron D, Smith DE, Badgaiyan RD, Gold MS.
J Syst Integr Neurosci. 2020 May 30;7:10.15761/JSIN.1000229. doi: 10.15761/JSIN.1000229. PMID: 32934823; PMCID: PMC7489288.